Jones Gareth W, Hill David G, Sime Katie, Williams Anwen S
Division of Infection and Immunity, Systems Immunity University Research Institute, School of Medicine, Cardiff University, Cardiff, Wales, UK.
Methods Mol Biol. 2018;1725:101-118. doi: 10.1007/978-1-4939-7568-6_9.
In vivo mouse models of inflammatory arthritis are extensively used to investigate pathogenic mechanisms governing inflammation-driven joint damage. Two commonly utilized models include collagen-induced arthritis (CIA) and methylated bovine serum albumin (mBSA) antigen-induced arthritis (AIA). These offer unique advantages for modeling different aspects of human disease. CIA involves breach of immunological tolerance resulting in systemic autoantibody-driven arthritis, while AIA results in local resolving inflammatory flares and articular T cell-mediated damage. Despite limitations that apply to all animal models of human disease, CIA and AIA have been instrumental in identifying pathogenic mediators, immune cell subsets and stromal cell responses that determine disease onset, progression, and severity. Moreover, these models have enabled investigation of disease phases not easily studied in patients and have served as testing beds for novel biological therapies, including cytokine blockers and small molecule inhibitors of intracellular signaling that have revolutionized rheumatoid arthritis treatment.
炎症性关节炎的体内小鼠模型被广泛用于研究炎症驱动的关节损伤的致病机制。两种常用的模型包括胶原诱导的关节炎(CIA)和甲基化牛血清白蛋白(mBSA)抗原诱导的关节炎(AIA)。这些模型在模拟人类疾病的不同方面具有独特优势。CIA涉及免疫耐受的破坏,导致全身性自身抗体驱动的关节炎,而AIA则导致局部炎症发作消退和关节T细胞介导的损伤。尽管适用于所有人类疾病动物模型的局限性存在,但CIA和AIA在识别决定疾病发作、进展和严重程度的致病介质、免疫细胞亚群和基质细胞反应方面发挥了重要作用。此外,这些模型使得对在患者中不易研究的疾病阶段进行研究成为可能,并已成为新型生物疗法的试验平台,包括细胞因子阻滞剂和细胞内信号传导的小分子抑制剂,这些疗法彻底改变了类风湿性关节炎的治疗。